Cost-effectiveness research

Merck/AARP "invitation only" conference on cost-effectiveness/outcomes research is set for Jan. 28. The stakeholders meeting, which will include the Agency for Healthcare Research & Quality as a key participant, will attempt to develop a consensus on standards for research. Wharton Health Care Systems Department Chairman Mark Pauly, MD, will moderate the meeting (1"The Pink Sheet" Nov. 10, 2003, p. 3). The Pharmaceutical Research & Manufacturers of America is expected to discuss a position on outcomes research during its next board meeting, Jan. 15...

Merck/AARP "invitation only" conference on cost-effectiveness/outcomes research is set for Jan. 28. The stakeholders meeting, which will include the Agency for Healthcare Research & Quality as a key participant, will attempt to develop a consensus on standards for research. Wharton Health Care Systems Department Chairman Mark Pauly, MD, will moderate the meeting (¹ (Also see "Rx Cost-Effectiveness Beyond Medicare: Merck, AARP Plan Policy Meeting" - Pink Sheet, 10 Nov, 2003.), p. 3). The Pharmaceutical Research & Manufacturers of America is expected to discuss a position on outcomes research during its next board meeting, Jan. 15....